Literature DB >> 19359629

Defining vasospasm after subarachnoid hemorrhage: what is the most clinically relevant definition?

Jennifer A Frontera1, Andres Fernandez, J Michael Schmidt, Jan Claassen, Katja E Wartenberg, Neeraj Badjatia, E Sander Connolly, Stephan A Mayer.   

Abstract

BACKGROUND AND
PURPOSE: Vasospasm is an important complication of subarachnoid hemorrhage, but is variably defined in the literature.
METHODS: We studied 580 patients with subarachnoid hemorrhage and identified those with: (1) symptomatic vasospasm, defined as clinical deterioration deemed secondary to vasospasm after other causes were eliminated; (2) delayed cerebral ischemia (DCI), defined as symptomatic vasospasm, or infarction on CT attributable to vasospasm; (3) angiographic spasm, as seen on digital subtraction angiography; and (4) transcranial Doppler (TCD) spasm, defined as any mean flow velocity >120 cm/sec. Logistic regression analysis was performed to test the association of each definition of vasospasm with various hospital complications, and 3-month quality of life (sickness impact profile), cognitive status (telephone interview of cognitive status), instrumental activities of daily living (Lawton score), and death or severe disability at 3 months (modified Rankin scale score 4-6), after adjustment for covariates.
RESULTS: Symptomatic vasospasm occurred in 16%, DCI in 21%, angiographic vasospasm in 31%, and TCD spasm in 45% of patients. DCI was statistically associated with more hospital complications (N=7; all P<0.05) than symptomatic spasm (N=4), angiographic spasm (N=1), or TCD vasospasm (N=1). Angiographic and TCD vasospasm were not related to any aspect of clinical outcome. Both symptomatic vasospasm and DCI were related to reduced instrumental activities of daily living, cognitive impairment, and poor quality of life (all P<0.05). However, only DCI was associated with death or severe disability at 3 months (adjusted OR, 2.2; 95% CI, 1.2-3.9; P=0.007).
CONCLUSIONS: DCI is a more clinically meaningful definition than either symptomatic deterioration alone or the presence of arterial spasm by angiography or TCD.

Entities:  

Mesh:

Year:  2009        PMID: 19359629     DOI: 10.1161/STROKEAHA.108.544700

Source DB:  PubMed          Journal:  Stroke        ISSN: 0039-2499            Impact factor:   7.914


  162 in total

1.  MR angiography in patients with subarachnoid hemorrhage: adequate to evaluate vasospasm-induced vascular narrowing?

Authors:  Elke Hattingen; Stella Blasel; Richard Dumesnil; Hartmut Vatter; Friedhelm E Zanella; Stefan Weidauer
Journal:  Neurosurg Rev       Date:  2010-06-08       Impact factor: 3.042

2.  Outcomes-based assessment of a new reference standard for delayed cerebral ischemia related to vasospasm in aneurysmal subarachnoid hemorrhage.

Authors:  Pina C Sanelli; Nikesh Anumula; Rachel Gold; Elliott Elias; Carl Johnson; Joseph Comunale; Apostolos J Tsiouris; Alan Z Segal
Journal:  Acad Radiol       Date:  2012-06-23       Impact factor: 3.173

3.  Relevance of cerebral interleukin-6 after aneurysmal subarachnoid hemorrhage.

Authors:  Asita Sarrafzadeh; Florian Schlenk; Christine Gericke; Peter Vajkoczy
Journal:  Neurocrit Care       Date:  2010-12       Impact factor: 3.210

4.  Role of CT perfusion imaging in the diagnosis and treatment of vasospasm.

Authors:  Edward D Greenberg; Y Pierre Gobin; Howard Riina; Carl E Johnson; Apostolos J Tsiouris; Joseph Comunale; Pina C Sanelli
Journal:  Imaging Med       Date:  2011-06-01

5.  Predictors of delayed cerebral ischemia after aneurysmal subarachnoid hemorrhage: a cardiac focus.

Authors:  Khalil Yousef; Elizabeth Crago; Chien-Wen Kuo; Michael Horowitz; Marilyn Hravnak
Journal:  Neurocrit Care       Date:  2010-12       Impact factor: 3.210

6.  Neutrophil depletion after subarachnoid hemorrhage improves memory via NMDA receptors.

Authors:  Jose Javier Provencio; Valerie Swank; Haiyan Lu; Sylvain Brunet; Selva Baltan; Rohini V Khapre; Himabindu Seerapu; Olga N Kokiko-Cochran; Bruce T Lamb; Richard M Ransohoff
Journal:  Brain Behav Immun       Date:  2016-02-09       Impact factor: 7.217

7.  The Role of Platelet Activation and Inflammation in Early Brain Injury Following Subarachnoid Hemorrhage.

Authors:  Jennifer A Frontera; J Javier Provencio; Fatima A Sehba; Thomas M McIntyre; Amy S Nowacki; Errol Gordon; Jonathan M Weimer; Louis Aledort
Journal:  Neurocrit Care       Date:  2017-02       Impact factor: 3.210

8.  Reduced-dose CT protocol for the assessment of cerebral vasospasm.

Authors:  N Bricout; L Estrade; F Boustia; E Kalsoum; J P Pruvo; X Leclerc
Journal:  Neuroradiology       Date:  2015-08-28       Impact factor: 2.804

Review 9.  SAHIT Investigators--on the outcome of some subarachnoid hemorrhage clinical trials.

Authors:  R Loch Macdonald; Blessing Jaja; Michael D Cusimano; Nima Etminan; Daniel Hanggi; David Hasan; Don Ilodigwe; Hector Lantigua; Peter Le Roux; Benjamin Lo; Ada Louffat-Olivares; Stephan Mayer; Andrew Molyneux; Audrey Quinn; Tom A Schweizer; Thomas Schenk; Julian Spears; Michael Todd; James Torner; Mervyn D I Vergouwen; George K C Wong; Jeff Singh
Journal:  Transl Stroke Res       Date:  2013-01-07       Impact factor: 6.829

10.  Augmented Renal Clearance in Patients with Subarachnoid Hemorrhage.

Authors:  Casey C May; Shaily Arora; Sara E Parli; Justin F Fraser; Melissa Thompson Bastin; Aaron M Cook
Journal:  Neurocrit Care       Date:  2015-12       Impact factor: 3.210

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.